ARISE Plus organised a workshop to discuss ASEAN Pharmaceutical Regulatory Framework (APRF) on 7th March 2022 for representatives of the Pharmaceutical Product Working Group (PPWG) and the ASEAN Health Cluster 3 (AHC 3).
The workshop was a follow up to previous discussions and has resulted in the preparation of a final draft of the APRF by the project. which was only possible after a full review of comments and inputs from AHC 3 and PPWG Members. The APRF will now be submitted for endorsement by ASEAN senior officials prior to adoption by ASEAN Ministers.
The adoption of the APRF, together with the ASEAN Pharmaceutical Regulatory Policy (APRP), which has been submitted for adoption, concludes the preparatory steps for the development of a legally binding ASEAN Pharmaceutical Regulatory Framework Agreement (APRF Agreement).
For more details, please visit: News on ASEAN Pharmaceutical Regulatory Framework – Principles and Outline
